Alzheimer’s groups vow to fight proposed Medicare restrictions on controversial drug
January 12th, 2022 by Global Down Syndrome Foundation
Alzheimer’s groups vow to fight proposed Medicare restrictions on controversial drug
The Washington Post | Jan 12, 2022
Medicare proposes limited coverage of controversial Alzheimer’s drug
January 11th, 2022 by Global Down Syndrome Foundation
Medicare proposes limited coverage of controversial Alzheimer’s drug
The Hill | Jan 11, 2022